Full-Time

Senior Director Quality

Posted on 11/23/2025

Mallinckrodt

Mallinckrodt

1,001-5,000 employees

Specialty pharmaceutical developer, manufacturer, distributor

No salary listed

St. Louis, MO, USA

In Person

Category
Biology & Biotech (2)
,
Requirements
  • Bachelor's degree in chemistry, microbiology or similar life sciences or technical field such as engineering, mathematics, etc.
  • Minimum of 15 years of pharmaceutical industry experience in a Quality Assurance and/or Regulatory Affairs function including experience in manufacturing and control of bulk drug substances, and solid dosage form drug products.
  • Minimum 5 years managerial experience in a pharmaceutical quality/regulatory affairs environment.
Responsibilities
  • Manages all aspects of plant Quality Systems including, CAPA, Supplier Quality, Change Control, in-process Quality Assurance, Quality Control, complaint management and validation functions.
  • Support an aggressive Quality program which instills personal accountability for accuracy, consistency and completeness for all operations and departments according to site and corporate policies.
  • Create and maintain an environment of excellence, world-class quality and continuous improvement throughout the entire plant.
  • Responsible to make fact-based, scientifically sound, quality decisions regarding products manufactured at the St. Louis Plant facility. These decisions must be made within the requirements of cGMPs and applicable regulatory/industry guidance documents.
  • Manage approval or rejection of starting materials, packaging materials, and intermediate, bulk and finished products per the appropriate regulations and documents.
  • Ensure the evaluation of batch records and that all necessary testing is carried out.
  • Approve specifications, sampling instructions, test methods and other QC procedures.
  • Ensure the authorization of all controlled documents, including records retention.
  • Ensure the monitoring and control of the manufacturing and Quality Control environments.
  • Ensure compliance with cGMP standards.
  • Ensure the appropriate process, equipment and facility validations meet expectations for validations, process capability, corrective actions and general compliance both for Corporate and for applicable regulatory agencies.
  • Coach and develop the team to High Performance while fostering a culture of team ownership.
  • Ensure team compliance with all policies, procedures and site/company regulations.
  • Set clear vision by ensuring goals and objectives are aligned with site strategies and managing each team member’s performance management.
  • Exhibit accountability and responsibility for an area or process in order to affect change and lead efforts and ideas to completion.
  • Provide leadership for employee relations through effective communications, coaching, training and development and eliminate roadblocks in order for the team to move forward.
  • Supply the highest level of internal and external customer service while having the ability to diplomatically challenge established procedures and systems.
  • Lead team in continuous improvement activities and take control when faced with adversity while incorporating team input.
  • Ensure proper maintenance and cleanliness of the department, premises and equipment.
  • Measure and communicate team’s progress against individual, team and site goals and Key Performance Indicators (KPI’s).
  • Lead and/or support investigations. Author, approve and/review area quality and safety exceptions and investigation reports. Ensure on-time completion of all corrective action items assigned to area.
  • Verify, review and make appropriate changes if needed, to any controlled document pertinent to area of responsibility.
  • Identify opportunities to reduce costs, reduce risk and improve service.
Desired Qualifications
  • Previous experience serving as a pharmaceutical manufacturing site leader of a significant quality function (Total Plant population >500 persons, Quality Function >100 persons).
  • Exceptional oral and written communication skills. Strong managerial and excellent negotiating skills in order to obtain balanced results from direct and indirect reports.
  • Knowledge of FDA and International regulations and guidances in the area of Quality Systems for pharmaceutical products and medical devices.
  • Experience interacting with regulatory agencies such as the FDA and EU regulatory bodies as an inspection host.
  • Strong patient and customer focus.
  • Strong writing skills to effectively communicate technical/clinical information to others.
  • Ability to use various software programs (Word, Excel, Power Point, Access) and a willingness to expand and increase these competencies.
  • Superior verbal communication skills including impeccable telephone etiquette.
  • Scientific literature searching and evaluation skills.

Mallinckrodt is a global specialty pharmaceutical company that develops, manufactures, and distributes drugs and therapies for complex and rare conditions, serving healthcare providers, hospitals, and patients mainly in the United States and Europe. Its products target areas such as autoimmune diseases, rare diseases, and critical care, and the business rests on research and development, manufacturing, and sales. The company differentiates itself through a patient-centric approach, a commitment to integrity, ongoing innovation, and collaboration, grounded in more than 150 years of experience and a focus on ESG initiatives. Its goal is to improve the health and well-being of patients worldwide by delivering specialty medicines and advancing sustainable practices.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Hazelwood, Missouri

Founded

1867

Simplify Jobs

Simplify's Take

What believers are saying

  • Merger with Endo completed, forming NYSE-listed therapeutics leader by Q4 2025.
  • Reduced debt 47% to $865.6M and grew Acthar Gel sales 14.2% in 2024.
  • Sold Therakos for $925M, optimizing portfolio for specialty pharmaceuticals.

What critics are saying

  • Endo merger integration disrupts operations, overloading with $6.7B debt.
  • Therakos sale drops immunotherapy revenue, losing edge to Amgen immediately.
  • Acthar Gel's $300K pricing triggers DOJ probe and $500M fines within 18 months.

What makes Mallinckrodt unique

  • Mallinckrodt specializes in Acthar Gel for autoimmune diseases over 150 years.
  • Focuses on rare diseases and critical care therapies for underserved patients.
  • Launched Acthar Gel self-injectable to improve patient adherence and convenience.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Relocation Assistance

Company News

PR Newswire
Nov 10th, 2025
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables

Launches as Top 15 U.S. Generic Drug Manufacturer, Largest U.S. Producer of Active Pharmaceutical Ingredients and Premier U.S. Producer of Sterile Injectables...

Contract Pharma
Aug 6th, 2025
Mallinckrodt Names Christiana Stamoulis President and CFO

Mallinckrodt plc appointed Christiana Stamoulis as President and Chief Financial Officer, effective September 22, 2025.

Stock Titan
Aug 1st, 2025
Mallinckrodt-Endo Merger Creates Therapeutics Leader

Mallinckrodt and Endo have completed a merger to form a global therapeutics leader. The companies will combine their generics businesses and Endo's sterile injectables business, which will be spun off as an independent company by Q4 2025. The newly branded company will be listed on the New York Stock Exchange following the spin-off.

The Business Journals
Jul 25th, 2025
Mallinckrodt Reaches $7B Merger Milestone

Mallinckrodt has reached a milestone in a $7 billion merger deal.

Sharecast
Mar 13th, 2025
Mallinckrodt and Endo to merge in $6.7bn deal

Pharmaceutical firm Mallinckrodt said on Thursday that it has agreed to merge with Endo in a $6.7bn deal.

INACTIVE